Fibroblast growth factor 21 is an independent predictor of prevalent and incident obstructive sleep apnea

Fibroblast growth factor 21 (FGF21) is a metabolic regulator and a potential biomarker of metabolic diseases. Limited data are available on the association between FGF21 and obstructive sleep apnea (OSA), which is considered as a manifestation of metabolic syndrome. In the present cross-sectional an...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Weijun, Zhang, Jingyu, Zou, Jianyin, Wang, Xiaoting, Xu, Huajun, Guan, Jian, Yi, Hongliang, Liu, Suru, Yin, Shankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926096/
https://www.ncbi.nlm.nih.gov/pubmed/36798439
http://dx.doi.org/10.1016/j.isci.2023.105985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926096/
https://www.ncbi.nlm.nih.gov/pubmed/36798439
http://dx.doi.org/10.1016/j.isci.2023.105985

Ejemplares similares